FDA Inspection
Lupin LimitedLupin Limited – FDA Inspection, May 19, 2017
Record Details
This FDA Inspection record concerns Lupin Limited, with an inspection on May 19, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b68ef947-578e-4234-90eb-16290766bd19
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1012540
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Lupin Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 17, 2025 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| March 29, 2023 | Not classified | Office of Inspections and Investigations | |
| January 25, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 23, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 22, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lupin Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.